466 related articles for article (PubMed ID: 26729493)
1. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A
Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
Cabot G; Bruchmann S; Mulet X; Zamorano L; Moyà B; Juan C; Haussler S; Oliver A
Antimicrob Agents Chemother; 2014 Jun; 58(6):3091-9. PubMed ID: 24637685
[TBL] [Abstract][Full Text] [Related]
4. Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
Cabot G; Florit-Mendoza L; Sánchez-Diener I; Zamorano L; Oliver A
J Antimicrob Chemother; 2018 Dec; 73(12):3322-3331. PubMed ID: 30189050
[TBL] [Abstract][Full Text] [Related]
5. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.
Cabot G; Ocampo-Sosa AA; Tubau F; Macia MD; Rodríguez C; Moya B; Zamorano L; Suárez C; Peña C; Martínez-Martínez L; Oliver A;
Antimicrob Agents Chemother; 2011 May; 55(5):1906-11. PubMed ID: 21357294
[TBL] [Abstract][Full Text] [Related]
7. Association of the exoU genotype with a multidrug non-susceptible phenotype and mRNA expressions of resistance genes in Pseudomonas aeruginosa.
Takata I; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):45-52. PubMed ID: 29107652
[TBL] [Abstract][Full Text] [Related]
8. Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.
Henrichfreise B; Wiegand I; Luhmer-Becker I; Wiedemann B
Antimicrob Agents Chemother; 2007 Oct; 51(10):3642-9. PubMed ID: 17682103
[TBL] [Abstract][Full Text] [Related]
9. Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
Moya B; Zamorano L; Juan C; Pérez JL; Ge Y; Oliver A
Antimicrob Agents Chemother; 2010 Mar; 54(3):1213-7. PubMed ID: 20086158
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
Zeng ZR; Wang WP; Huang M; Shi LN; Wang Y; Shao HF
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
[TBL] [Abstract][Full Text] [Related]
12. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
14. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
[TBL] [Abstract][Full Text] [Related]
15. In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.
Solé M; Fàbrega A; Cobos-Trigueros N; Zamorano L; Ferrer-Navarro M; Ballesté-Delpierre C; Reustle A; Castro P; Nicolás JM; Oliver A; Martínez JA; Vila J
J Antimicrob Chemother; 2015 Nov; 70(11):3004-13. PubMed ID: 26260130
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic detection of antibiotic resistance of
Abbas HA; El-Ganiny AM; Kamel HA
Afr Health Sci; 2018 Mar; 18(1):11-21. PubMed ID: 29977252
[TBL] [Abstract][Full Text] [Related]
17. PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.
Blázquez J; Gómez-Gómez JM; Oliver A; Juan C; Kapur V; Martín S
Mol Microbiol; 2006 Oct; 62(1):84-99. PubMed ID: 16956383
[TBL] [Abstract][Full Text] [Related]
18. Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Moyá B; Beceiro A; Cabot G; Juan C; Zamorano L; Alberti S; Oliver A
Antimicrob Agents Chemother; 2012 Sep; 56(9):4771-8. PubMed ID: 22733064
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
Pasca MR; Dalla Valle C; De Jesus Lopes Ribeiro AL; Buroni S; Papaleo MC; Bazzini S; Udine C; Incandela ML; Daffara S; Fani R; Riccardi G; Marone P
Microb Drug Resist; 2012 Feb; 18(1):23-32. PubMed ID: 21797666
[TBL] [Abstract][Full Text] [Related]
20.
Fraile-Ribot PA; Mulet X; Cabot G; Del Barrio-Tofiño E; Juan C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
